Global auto-injector contract manufacturing market worth $2.80 billion by 2030 – InsightAce Analytic

Global Auto-Injector Contract Manufacturing Market Insights

Global auto-injector contract manufacturing market segmentation

Global auto-injector contract manufacturing market segmentation

The global auto-injector contract manufacturing market will be valued at 1.16 Billion US$ in 2021. It is expected to reach 2.80 Billion US$ by 2030

The major market players in the contract manufacturing of auto-injectors market are Stevanato Group, Gerresheimer AG, Haselmeier, Elcam Drug Delivery Devices (E3D), Jabil Healthcare, SHL Medical »

— Insightace analysis

NEW JERSEY, NJ, USA, September 13, 2022 /EINPresswire.com/ — InsightAce Analytics Pvt. announces the publication of a market assessment report on the “Global auto-injector contract manufacturing market– by product (disposable auto-injectors, reusable auto-injectors, portable injector and smart/connected auto-injectors), application (anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes and others), end user (homecare, hospitals and Clinics and Ambulatory Services), Trends, Industry Competitive Analysis, Revenue and Forecast to 2030.

Request for sample pages: https://www.insightaceanalytic.com/request-sample/1340

According to the latest research from InsightAce Analytic, the global auto-injector contract manufacturing market will be valued at US$1.16 billion in 2021. It is expected to reach US$2.80 billion by 2030, with a CAGR of 10.4% over a forecast period of 2022.-2030.

Self-injection devices allow rapid administration of drugs and antidotes, which people can use even without medical training. They are therefore effective in managing emergencies and large numbers of casualties. For self-administration of epinephrine (to prevent anaphylaxis), by migraine patients (for immediate pain relief), and for medical and emergency treatment, auto-injectors are frequently used. Patients with diseases requiring many daily injections are increasingly using auto-injectors.

Rising incidences of rheumatoid arthritis, multiple sclerosis, diabetes, and growth hormone abnormalities in patients is one of the major factors driving the auto-injector contract manufacturing market . Because they allow patients to inject their prescriptions without hesitation due to a phobia of needle-based medication delivery technique, auto-injectors are becoming increasingly popular. Auto-injectors can be used anywhere without disturbing the user or anyone nearby. Since the main body of the device does not need to be changed after each injection, auto-injectors reduce the cost per injection for the user. The development of the auto-injector contract manufacturing business is being held back by increased corporate R&D efforts to create easily accessible, economically viable, and technology-based auto-injectors for the treatment of chronic diseases. However, the preference for other methods of drug delivery, such as oral diabetes medications and epinephrine nasal sprays, should reduce the need for self-injection devices. Market growth is further constrained by the development of needle-free drug delivery techniques such as jet injectors.

North America is expected to primarily contribute to the auto-injector contract manufacturing market. Injections are a common treatment for many older people in the region, especially those with rheumatoid arthritis and diabetes. The major insurance programs in the region have also contributed to the growth of the auto-injector contract manufacturing market. In addition, the auto-injector contract manufacturing market in Asia Pacific is expected to register significant growth. The region’s market is expanding mainly due to the high prevalence of diabetes and the development of healthcare infrastructure, which has attracted several well-known manufacturers of auto-injectors here.

Major market players operating in the auto-injector contract manufacturing market include Phillips-Midsize (a Molex company), Elcam Drug Delivery Devices (E3D) (Elcam Medical), Jabil Healthcare, Dali Medical Devices, Ypsomed Delivery Systems (YDS), SHL Medical, Haselmeier, Owen Mumford, Becton, Dickinson and Company (BD), CCBio, Nemera (Copernicus), Recipharm AB, Sonceboz, Solteam Medical, Stevanato Group, Union Medico ApS., Neuma Engineering, Emperra, Eitan Medical, Enable Injections, West Pharmaceutical Services, Inc., Delfi Medical, Wanchai Medical and other prominent players.

Recent collaborations and agreements on the market:
• In June 2022, sustainable drug delivery becomes a major concern for the pharmaceutical industry, which is why Jabil Healthcare launched the Xfinity autoinjector platform, a reusable and modular solution for self-administration under -cutaneous (SC) drugs. Using integrated sensors and electronics, the Qfinity+ auto-injector, a linked version of the handheld device, allows medical teams to remotely monitor their patients’ treatment and compliance.
• In May 2021, the Aria Smart Autoinjector platform was introduced by Phillips-Medisize to drive innovation, distinctiveness and sustainability in the digital drug delivery device market. This latest innovation will improve patient care with less environmental impact through a small, simple and smart injection device with a reusable electronic drive unit and single-use disposable cassettes.

Curious about this latest version of the report? Get report details @ https://www.insightaceanalytic.com/enquiry-before-buying/1340

Market segments
Global Auto-Injector Contract Manufacturing Market, by Product, 2022-2030 (Value in Million US$)
• Disposable auto-injectors
• Reusable auto-injectors
• Portable injector
• Smart/connected auto-injectors

Global Auto-Injector Contract Manufacturing Market, by Application, 2022-2030 (Value in Million US$)
• Anaphylaxis
• Rheumatoid arthritis
• Multiple sclerosis
• Diabetes
• Others

Global auto-injector contract manufacturing market, by end-user, 2022-2030 (Value in Million US$)
• Home Care
• Hospitals and clinics
• Ambulatory services

Global Auto-Injector Contract Manufacturing Market, by Region, 2022-2030 (Value in Million US$)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

North America Auto-Injector Contract Manufacturing Market, by Country, 2022-2030 (Value in Million US$)
• WE
• Canada

Europe auto-injector contract manufacturing market, by country, 2022-2030 (Value in Million US$)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia-Pacific auto-injector contract manufacturing market, by country, 2022-2030 (Value in Million US$)
• India
• China
• Japan
• South Korea
• Australia and New Zealand

Latin America auto-injector contract manufacturing market, by country, 2022-2030 (Value in Million US$)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Auto-Injector Contract Manufacturing Market, by Country, 2022-2030 (Value in Million US$)
• GCC countries
• South Africa
• Rest of the Middle East and Africa

Why buy this report:
 Receive a comprehensive outlook analysis of the Global Auto-Injector Contract Manufacturing Market
 To receive industry insight and future trends in the Contract Manufacturing of Auto-Injectors market
 Analyze auto injector contract manufacturing market drivers and challenges
 To obtain insights on the Auto-Injectors Contract Manufacturing Market value (Million US$) forecasted to 2030
 Significant investments, mergers and acquisitions in the Auto-Injector Contract Manufacturing market industry

For more information @ https://www.insightaceanalytic.com/customization/1340

Priyanka Tilekar
Insightace Analytical Pvt. ltd.
+1 551-226-6109
write to us here

Comments are closed.